Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-9.43	58.03	64.08
Graham Fair Price	9.36	28.20	25.79
PEG	inf	0.00	30.75
Price/Book	-13.40	3.52	4.07
Price/Cash Flow	25.11	91.63	73.24
Prices/Earnings	-19.80	23.26	29.01
Price/Sales	-12.00	16.54	18.79
Price/FCF	25.11	91.63	73.24
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-0.76	0.60	0.60
Operating Margin	-9.04	0.17	0.19
ROA	8.45	0.02	0.02
ROE	0.04	0.04	7.98
ROIC	0.02	0.02	1.55
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	< 0.005	< 0.005	8.29
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	0.05	-0.10	98.82
EPS QOQ	< 0.005	0.00	inf
FCF QOQ	0.58	-0.30	-47.67
Revenue QOQ	0.03	< 0.005	-73.56
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	39.84	< 0.005	-100.00
Days Sales Outstanding (DSO)	65.51	65.35	-0.25
Inventory Turnover	2.26	394743000.00	17474083264.90
Debt/Capitalization	0.50	0.50	< 0.005
Quick Ratio	1.90	2.96	55.56
Naive Interpretation	member

04 - Leverage & Liquidity · Balanced

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	29.04	30.56	5.24
Cash	5.46	11.04	102.26
Capex	-0.85	-1.15	-35.49
Free Cash Flow	1.61	1.17	-27.16
Revenue	6.29	6.51	3.56
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	2.16	3.25	50.32
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	11.40	11.66	2.31
Naive Interpretation	Member

06 - Financial Health · Bad

Rating